Circulating T cells in patients with untreated acute myelogenous leukemia are heterogeneous and can be activated through the CD3/TCR complex

References

• Smith M, Barnett M, Bassan R, Gatta G, Tondini C, Kern W. Adult acute myeloid leukaemia. Crit Rev Oncol Hematol 2004;50:197–222.
   PubMed Web of Science ®Google Scholar
• Bruserud O, Foss B, Petersen H. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: Studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (F1t3L). Eur Cytokine Netw 2001;12: 231–238.
   PubMed Web of Science ®Google Scholar
• Wendelbo O, Nesthus I, Sjo M, Paulsen K, Ernst P, Bruserud O. Functional characterization of T lymphocytes derived from patients with acute myelogenous leukemia and chemo-therapy-induced leukopenia. Cancer Immunol Immunother 2004;53:740–747.
   PubMed Web of Science ®Google Scholar
• Mackall CL. T-cell immunodeficiency following cytotoxic antineoplastic therapy: A review. Stem Cells 2000;18:10–18.
   PubMed Web of Science ®Google Scholar
• Hakim FT, Cepeda R, ICaimei S, Mackall CL, McAtee N, Zujewski J. Constraints on CD4 recovery postchemotherapy in adults: Thymic insufficiency and apoptotic decline of expanded peripheral CD4 cells. Blood 1997;90:3789–3798.
   PubMed Web of Science ®Google Scholar
• Mackall CL, Fleisher TA, Brown MR, Andrich MP, Chen CC, Feuerstein IM. Distinctions between CD8 + and CD4 + T-cell regenerative pathways result in prolonged T-cell subset imbalance after intensive chemotherapy. Blood 1997;89:3700–3707.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Inwards DJ, Micallef IN, Ansell SM, Geyer SM, Markovic SN. Early lymphocyte recovery post-autologous haematopoietic stem cell transplantation is associated with better survival in Hodgkin's disease. Br J Haematol 2002;117:629–633.
   PubMed Web of Science ®Google Scholar
• Behl D, Porrata LF, Markovic SN, Letendre L, Pruthi RK, Hook CC, et at. Absolute lymphocyte count recovery after induction chemotherapy predicts superior survival in acute myelogenous leukemia. Leukemia 2006;20:29–34.
   Google Scholar
• Porrata LF, Litzow MR, Tefferi A, Letendre L, Kumar S, Geyer SM, et al. Early lymphocyte recovery is a predictive factor for prolonged survival after autologous hematopoietic stem cell transplantation for acute myelogenous leukemia. Leukemia 2002;16:1311–1318.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Gertz MA, Inwards DJ, Litzow MR, Lacy MQ, Tefferi A, et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplanta-tion in multiple myeloma or non-Hodgkin lymphoma. Blood 2001;98:579–585.
   PubMed Web of Science ®Google Scholar
• Porrata LF, Ingle JN, Litzow MR, Geyer S, Markovic SN. Prolonged survival associated with early lymphocyte recovery after autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer. Bone Marrow Transplant 2001;28:865–871.
   Google Scholar
• Porrata LF, Gertz MA, Litzow MR, Lacy MQ, Dispenzieri A, Inwards DJ, et al. Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplan-tation for patients with primary systemic amyloidosis. Clin Cancer Res 2005;11:1210–1218.
   PubMed Web of Science ®Google Scholar
• Panoskaltsis N, Reid CD, Knight SC. Quantification and cytokine production of circulating lymphoid and myeloid cells in acute myelogenous leukaemia. Leukemia 2003;17:716–730.
   Google Scholar
• Bruserud O, Ryningen A, Wergeland L, Glenjen NI, Gjertsen BT. Osteoblasts increase proliferation and release of pro-angiogenic interleukin 8 by native human acute myelogenous leukemia blasts. Haematologica 2004;89: 391–402.
   PubMed Web of Science ®Google Scholar
• Wendelbo O, Bruserud O. Functional evaluation of prolif-erative T cell responses in patients with severe T lymphopenia: Characterization of optimal culture conditions and standar-dized activation signals for a simple whole blood assay. J Hematother Stem Cell Res 2003;12:525–535.
   PubMedGoogle Scholar
• Bruserud O, Ulvestad E. Acute myelogenous leukemia blasts as accessory cells during in vitro T lymphocyte activation. Cell Immunol 2000;206:36–50.
   PubMed Web of Science ®Google Scholar
• Hampson P, Chahal H, Khanim F, Hayden R, Mulder A, Assi LK, et al. PEP005, a selective small-molecule activator of protein kinase C, has potent antileukemic activity mediated via the delta isoform of PKC. Blood 2005;106:1362–1368.
   PubMed Web of Science ®Google Scholar
• Bruserud O, Wendelboe O. Biological treatment in acute myelogenous leukaemia: How should T-cell targeting immunotherapy be combined with intensive chemotherapy? Expert Opin Biol Ther 2001;1:1005–1016.
   PubMed Web of Science ®Google Scholar
• Bruserud O, Ulvestad E, Berentsen S, Bergheim J, Nesthus I. T-lymphocyte functions in acute leukaemia patients with severe chemotherapy-induced cytopenia: Characteriz-ation of clonogenic T-cell proliferation. Scand J Immunol 1998;47:54–62.
   Google Scholar
• Bruserud O. Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells. Cancer Immunol Immunother 1998;46:221–228.
   PubMed Web of Science ®Google Scholar
• Mackall CL, Fleisher TA, Brown MR, Magrath IT, Shad AT, Horowitz ME, et al. Lymphocyte depletion during treatment with intensive chemotherapy for cancer. Blood 1994;84:2221–2228.
   PubMed Web of Science ®Google Scholar
• Mackall CL, Stein D, Fleisher TA, Brown MR, Hakim FT, Bare CV, et al. Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults. Blood 2000;96: 754–762.
   PubMed Web of Science ®Google Scholar
• Vidriales MB, Orfao A, Lopez-Berges MC, Gonzalez M, Hernandez JM, Ciudad J, et al. Lymphoid subsets in acute myeloid leukemias: Increased number of cells with NK phenotype and normal T-cell distribution. Ann Hematol 1993;67:217–222.
   Google Scholar
• Wang X, Zheng J, Liu J, Yao J, He Y, Li X, et al. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients. Eur J Haematol 2005;75:468–476.
   PubMed Web of Science ®Google Scholar
• Jahn B, Bergmann L, Weidmann E, Brieger J, Fenchel K, Schwulera U, et at. Bone marrow-derived T-cell clones obtained from untreated acute myelocytic leukemia exhibit blast directed autologous cytotoxicity. Leuk Res 1995;19:73–82.
   Google Scholar
• Feuerer M, Beckhove P, Garbi N, Mahnke Y, Limmer A, Hommel M, et al. Bone marrow as a priming site for T-cell responses to blood-borne antigen. Nat Med 2003; 9:1151–1157.
   PubMed Web of Science ®Google Scholar
• Effros RB, Dagarag M, Spaulding C, Man J. The role of CD8 + T-cell replicative senescence in human aging. Immu-nol Rev 2005;205:147–157.
   PubMed Web of Science ®Google Scholar
• De Rosa SC, Herzenberg LA, Herzenberg LA, Roederer M. 11-Color, 13-parameter flow cytometry: Identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat Med 2001;7:245–248.
   PubMed Web of Science ®Google Scholar
• Song K, Rabin RL, Hill BJ, De Rosa SC, Perfetto SP, Zhang HH, et al. Characterization of subsets of CD4 + memory T cells reveals early branched pathways of T cell differentiation in humans. Proc Natl Acad Sci USA 2005;102: 7916–7921.
   PubMed Web of Science ®Google Scholar
• Sallusto F, Lenig D, Forster R, Lipp M, Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999;401: 708–712.
   Google Scholar
• Ogboume SM, Suhrbier A, Jones B, Cozzi Si, Boyle GM, Morris M, et al. Antitumor activity of 3-ingenyl angelate: Plasma membrane and mitochondrial disruption and necrotic cell death. Cancer Res 2004;64:2833–2839.
   PubMed Web of Science ®Google Scholar
• Kedei N, Lundberg DJ, Toth A, Welburn P, Garfield SH, Blumberg PM. Characterization of the interaction of ingenol 3-angelate with protein kinase C. Cancer Res 2004;64: 3243–3255.
   PubMed Web of Science ®Google Scholar
• Mrozek K, Heerema NA, Bloomfield CD. Cytogenetics in acute leukemia. Blood Rev 2004;18:115–136.
   PubMed Web of Science ®Google Scholar